1. Discontinuation of anti‑programmed cell death protein 1 immune checkpoint inhibition after complete remission in head and neck squamous cell carcinoma: A case report and literature review
   Manuel Stöth et al, 2023, Oncology Letters CrossRef
2. In Vitro Models of Head and Neck Cancer: From Primitive to Most Advanced
   Irina Arutyunyan et al, 2023, Journal of Personalized Medicine CrossRef
3. Dual Site-Specific Chemoenzymatic Antibody Fragment Conjugation Using CRISPR-Based Hybridoma Engineering
   Camille M. Le Gall et al, 2021, Bioconjugate Chemistry CrossRef
4. Effect of neoadjuvant chemotherapy and its correlation with HPV status, EGFR, Her-2-neu, and GADD45 expression in oral squamous cell carcinoma
   Manoj Pandey et al, 2018, World Journal of Surgical Oncology CrossRef
5. Tumor microenvironment-responsive docetaxel-loaded micelle combats metastatic breast cancer
   Tianqun Lang et al, 2019, Science Bulletin CrossRef
6. The Acute Toxicities and Efficacy of Concurrent Chemotherapy With Docetaxel Plus Cisplatin, or Docetaxel, or Cisplatin and Helical Tomotherapy in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma: A Randomized Single-Center Phase II Trial
   Yanrong Luo et al, 2022, Technology in Cancer Research & Treatment CrossRef
7. Combined Therapy for the Treatment of Cancer
   Iago Dillion Lima Cavalcanti, 2022, Chemotherapy Protocols and Infusion Sequence CrossRef
8. Tumor Cells‐Selective Bionic Nanodevice Exploiting Heparanase Combats Metastatic Breast Cancer
   Tianqun Lang et al, 2018, Advanced Functional Materials CrossRef
9. Targeting feedback activation of signaling transduction pathways to overcome drug resistance in cancer
   Xuejian Wang et al, 2022, Drug Resistance Updates CrossRef
10. Evaluation of a docetaxel-cisplatin-fluorouracil-Au complex in human oral carcinoma cell line
    Wannisa Khamaikawin et al, 2023, Artificial Cells, Nanomedicine, and Biotechnology CrossRef
11. Reactive oxygen species in cancer stem cells of head and neck squamous cancer
    Xu Qian et al, 2018, Seminars in Cancer Biology CrossRef
12. Metabolomic Insight into Implications of Induction Chemotherapy Followed by Concomitant Chemoradiotherapy in Locally Advanced Head and Neck Cancer
    Łukasz Boguszewicz et al, 2023, International Journal of Molecular Sciences CrossRef
13. pN status predicts outcomes in surgically treated pT1–pT2 patients of various disease stages with squamous cell carcinoma of the head and neck: a 17-year retrospective single center cohort study
    Xu Qian et al, 2018, European Archives of Oto-Rhino-Laryngology CrossRef
14. Aldehyde dehydrogenase 1 isoenzyme expression as a marker of cancer stem cells correlates to histopathological features in head and neck cancer: A meta-analysis
    Yue Dong et al, 2017, PLOS ONE CrossRef
15. Assessment of a Nano-Docetaxel Combined Treatment for Head and Neck Cancer
    Gee Young Lee et al, 2021, Onco CrossRef
16. Predictive Biomarkers for Response and Toxicity of Induction Chemotherapy in Head and Neck Cancers
    Łukasz Boguszewicz, 2022, Frontiers in Oncology CrossRef
17. Capecitabine—A “Permanent Mission” in Head and Neck Cancers “War Council”?
    Camil Ciprian Mireștean et al, 2022, Journal of Clinical Medicine CrossRef
18. Platelet-lymphocyte and neutrophil-lymphocyte ratios
    Yu-Hsi Liu et al, 2019, Journal of the Chinese Medical Association CrossRef
19. Molecular response to induction chemotherapy and its correlation with treatment outcome in head and neck cancer patients by means of NMR-based metabolomics
    Łukasz Boguszewicz et al, 2021, BMC Cancer CrossRef